Kromek Group (LON:KMK) has been awarded US$1.8mln in funding from the US Department of Defense to help develop a next-generation radionuclide identification device for detecting radioactive substances.
The company, which makes radiation detection technology for the medical, security and nuclear markets, said the funding will be delivered over two years of the project period.
The contract is under a previously announced agreement with the defence department’s Defense Threat Reduction Agency (DTRA) to develop the technology, which Kromek said will be used to meet future military operational challenges.
READ: Kromek inks two new contracts with US government
Kromek will enhance its D3S platform to develop a next-generation, ruggedised small form factor for use in the military field.
The group said by using advanced detector materials, the device will generate “higher resolution detection and superior localisation and identification” of radioactive material for use by the US military.
“We are seeing considerable traction for our D3S radiation detectors as they continue to prove their efficacy in the security markets globally,” said Kromek chief executive Dr Arnab Basu.
He added: “Our long-term relationship with multiple agencies of the US Department of Defense is the result of a shared commitment to develop next-generation technology and we look forward to continuing this work with the DTRA."